HSPH in in pressing for the control of tobacco and smoking.

It iss extend its application to the marketing Authorisationfor ZometaThe European Medicines Agency has been formally notified by Novartis Pharma AG of its decision to withdraw the application to extend the authorization to a new indication for the drug Zometa .

In its official letter, the company said, that the withdrawal of the application was based on the CHMP consideration that the data provided did not allow them to recommend a permit for the extension of the indication.HSPH in in pressing for the control of tobacco and smoking. In December 2006 a professor Dimitrios Trichopoulos which School Department of Epidemiology the health consequences the health effects in ETS exposure and connect you to an increased in lung cancer risk humans never smoked.

Both comments and pings are currently closed.

Comments are closed.

Powered by WordPress | Designed by: redshirtarmy.com | Thanks to redshirtarmy.com